• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺肿瘤中前列腺干细胞抗原表达的 MRI 研究。

MRI of prostate stem cell antigen expression in prostate tumors.

机构信息

Department of Radiology, Fourth Military Medical University, Xian 710032, China.

出版信息

Nanomedicine (Lond). 2012 May;7(5):691-703. doi: 10.2217/nnm.11.147.

DOI:10.2217/nnm.11.147
PMID:22630152
Abstract

BACKGROUND

The prostate stem cell antigen (PSCA) is broadly overexpressed on the surface of prostate cancer cells.

MATERIALS & METHODS: Anti-human PSCA monoclonal antibody (mAb 7F5) was bound to Fe(3)O(4)/Au (GoldMag) nanoparticles to serve as a PSCA-specific molecular MRI probe (mAb 7F5@GoldMag) for in vivo detection of prostate cancer cells. First, the efficacy of the antibody immobilization for the binding was assessed. Next, PC-3 (human prostate cancer cell line with PSCA overexpression) tumor-bearing mice were injected with mAb 7F5@GoldMag for MRI measurements while using mouse anti-human IgG bound to the particles (IgG@GoldMag) to serve as a nonspecific control. MRI examinations were conducted before and after injection of these probes at 6, 12 and 24 h; T2-weighted signal intensity within the tumors was measured.

RESULTS

Targeted binding of the mAb 7F5@GoldMag probe to PC-3 tumors was verified with optical images and MRI; selective binding was not observed for the nonspecific IgG@GoldMag probe.

CONCLUSION

MRI measurements suggest the promising efficacy of this new approach for targeted molecular imaging of prostate tumors.

摘要

背景

前列腺干细胞抗原 (PSCA) 在前列腺癌细胞表面广泛过表达。

材料与方法

抗人 PSCA 单克隆抗体 (mAb 7F5) 与 Fe(3)O(4)/Au(GoldMag)纳米颗粒结合,作为用于体内检测前列腺癌细胞的 PSCA 特异性分子 MRI 探针 (mAb 7F5@GoldMag)。首先,评估了抗体固定用于结合的效果。接下来,将 PSCA 过表达的 PC-3(人前列腺癌细胞系)荷瘤小鼠注射 mAb 7F5@GoldMag 进行 MRI 测量,同时使用与颗粒结合的小鼠抗人 IgG(IgG@GoldMag)作为非特异性对照。在注射这些探针之前和之后的 6、12 和 24 h 进行 MRI 检查;测量肿瘤内的 T2 加权信号强度。

结果

通过光学图像和 MRI 验证了 mAb 7F5@GoldMag 探针与 PC-3 肿瘤的靶向结合;未观察到非特异性 IgG@GoldMag 探针的选择性结合。

结论

MRI 测量结果表明,这种新方法在靶向前列腺肿瘤分子成像方面具有很大的应用潜力。

相似文献

1
MRI of prostate stem cell antigen expression in prostate tumors.前列腺肿瘤中前列腺干细胞抗原表达的 MRI 研究。
Nanomedicine (Lond). 2012 May;7(5):691-703. doi: 10.2217/nnm.11.147.
2
MRl of prostate cancer antigen expression for diagnosis and immunotherapy.用于诊断和免疫治疗的前列腺癌抗原表达的 MRI 研究。
PLoS One. 2012;7(6):e38350. doi: 10.1371/journal.pone.0038350. Epub 2012 Jun 27.
3
The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancer.I131-PSCA-mAb 在前列腺癌原位模型小鼠中的治疗效果。
Eur J Med Res. 2013 Dec 13;18(1):56. doi: 10.1186/2047-783X-18-56.
4
Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.抗前列腺干细胞抗原半胱氨酸二联体用于胰腺癌的免疫 PET/近红外荧光双模态成像。
J Nucl Med. 2018 Sep;59(9):1398-1405. doi: 10.2967/jnumed.117.207332. Epub 2018 Mar 30.
5
Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.基于双抗原靶向免疫疗法的前列腺癌治疗方案可消除小鼠体内已建立肿瘤的生长。
Immunotherapy. 2011 Jun;3(6):735-46. doi: 10.2217/imt.11.59.
6
RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.靶向PSCA的RNA干扰抑制SCID小鼠体内人前列腺癌异种移植瘤的原发性肿瘤生长和转移形成。
Prostate. 2016 Feb;76(2):184-98. doi: 10.1002/pros.23110. Epub 2015 Oct 19.
7
The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.多种生物信息学工具产生的新型抗 PSCA 肽抗体对前列腺癌细胞的抗增殖作用。
Recent Pat Anticancer Drug Discov. 2021;16(1):73-83. doi: 10.2174/1574892815999201110212411.
8
Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery.载前列腺干细胞抗原抗体的多壁碳纳米管用于靶向超声成像和药物递送。
Biomaterials. 2014 Jul;35(20):5369-5380. doi: 10.1016/j.biomaterials.2014.03.038. Epub 2014 Apr 5.
9
Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.通过新型抗体靶向模块化系统重定向 CD4+和 CD8+T 淋巴细胞,可有效杀伤 PSCA+前列腺肿瘤细胞。
Prostate. 2014 Sep;74(13):1347-58. doi: 10.1002/pros.22851. Epub 2014 Jul 22.
10
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.前列腺干细胞抗原:一种在前列腺癌中过度表达的细胞表面标志物。
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1735-40. doi: 10.1073/pnas.95.4.1735.

引用本文的文献

1
Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents.用于抗癌和抗病毒治疗诊断剂的金属及金属氧化物纳米颗粒和纳米系统。
Pharmaceutics. 2023 Apr 7;15(4):1181. doi: 10.3390/pharmaceutics15041181.
2
Magnetic Nanoparticles as MRI Contrast Agents.磁性纳米颗粒作为 MRI 对比剂。
Top Curr Chem (Cham). 2020 May 7;378(3):40. doi: 10.1007/s41061-020-00302-w.
3
In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless.
通过将抗前列腺干细胞抗原(PSCA)抗体定向偶联到超顺磁性氧化铁纳米颗粒上进行体外前列腺癌生物标志物检测。
Med J Islam Repub Iran. 2019 Mar 12;33:16. doi: 10.34171/mjiri.33.16. eCollection 2019.
4
Magnetic nanoformulations for prostate cancer.用于前列腺癌的磁性纳米制剂。
Drug Discov Today. 2017 Aug;22(8):1233-1241. doi: 10.1016/j.drudis.2017.04.018. Epub 2017 May 16.
5
In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles.使用多肽标记的超顺磁性氧化铁纳米颗粒靶向前列腺特异性膜抗原进行前列腺癌的体内分子磁共振成像
Int J Mol Sci. 2015 Apr 28;16(5):9573-87. doi: 10.3390/ijms16059573.
6
Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles.铁氧化物内核金壳纳米粒子光热消融胰腺癌细胞。
Int J Nanomedicine. 2013;8:3437-46. doi: 10.2147/IJN.S47585. Epub 2013 Sep 6.
7
Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen.功能化磁性纳米颗粒用于细胞表面抗原的检测和定量分析。
Biomed Res Int. 2013;2013:349408. doi: 10.1155/2013/349408. Epub 2012 Dec 31.